Zobrazeno 1 - 2
of 2
pro vyhledávání: '"679"'
Autor:
Gemlo BT; Department of Surgery, University of California, San Francisco 94143., Palladino MA Jr, Jaffe HS, Espevik TP, Rayner AA
Publikováno v:
Cancer research [Cancer Res] 1988 Oct 15; Vol. 48 (20), pp. 5864-7.
Publikováno v:
Cancer research. 48(20)
Treatment with recombinant interleukin 2 and lymphokine-activated killer cells (rIL-2/LAK) has produced a clinical antitumor effect in preliminary human trials. The cytokines gamma-interferon (IFN-gamma), tumor necrosis factor alpha (TNF-alpha), and